# Screening for Fabry Disease in Renal Transplantation

> **NCT03886714** · — · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 592 (actual)

## Conditions studied

- Fabry Disease
- Nephropathy

## Interventions

- **DIAGNOSTIC_TEST:** Screening for Fabry disease
- **DIAGNOSTIC_TEST:** Screen for α-galactosidase mutation

## Key facts

- **NCT ID:** NCT03886714
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-25
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-04-10
- **Target enrollment:** 592 (ACTUAL)
- **Why stopped:** Low recreuitement numbers and end of grant.
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03886714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03886714, "Screening for Fabry Disease in Renal Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03886714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*